Moderna faces weak post-pandemic vaccine demand and financial struggles, with limited near-term catalysts. Click here to read ...

The CDC expanded RSV vaccine recommendations to include adults aged 50 and above who have underlying health conditions ...

Following various phone and smartwatch apps (Fitbits, fitness trackers, etc.), people have been focusing on taking 10,000 ...

It is still very early days, but GSK’s respiratory syncytial virus (RSV) Arexvy seems to have flown out of the traps more quickly than Pfizer’s rival shot Abrysvo in the first weeks since they ...

I foresee declining vaccine sales, tariff impacts, and ongoing litigation involving Zantac, amidst an environment of potentially misplaced R&D efforts—prioritizing the launch of Arexvy to ...

The Abrysvo and Arexvy vaccines come with a warning about a potential increased risk of a rare immune condition called Guillain-Barré syndrome.

Visitors at the Kentucky State Fair are able to get free health screenings again this year. WellCare of Kentucky is ...

The FDA has extended the review period for elinzanetant for the treatment of moderate to severe vasomotor symptoms due to menopause.